The End of an Era: Withdrawal of Xiapex (Clostridium histolyticum Collagenase) from the European Market
Author:
Publisher
Elsevier BV
Subject
Urology
Reference7 articles.
1. Prospective observation of Clostridium histolyticum collagenase for the treatment of Dupuytren’s disease in 788 patients: the Austrian register;Arora;Arch Orthop Trauma Surg,2019
2. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of Peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies;Gelbard;J Urol,2013
3. Predictive factors of patients’ and their partners’ sexual function improvement after collagenase Clostridium histolyticum injection for Peyronie’s disease: results from a multi-center single-arm study;Cocci;J Sex Med,2018
4. Clinical efficacy of injection and mechanical therapy for Peyronie’s disease: a systematic review of the literature;Russo;Eur Urol,2018
5. Predictors of treatment success after collagenase Clostridium histolyticum injection for Peyronie’s disease: development of a nomogram from a multicentre single-arm, non-placebo controlled clinical study;Cocci;BJU Int,2018
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Acute Phase Peyronie’s Disease: Where Do We Stand?;Cureus;2024-08-17
2. Penile prosthesis implantation is safe and effective in Peyronie’s disease patients with and without erectile dysfunction;International Journal of Impotence Research;2024-06-22
3. Dorsal Penile Artery Avulsion After Collagenase Clostridium histolyticum (Xiaflex) for Peyronie’s Disease: A Case Report;JU Open Plus;2024-06
4. Dupuytren's Disease: A Novel Minimally Invasive Pull-Through Technique;Archives of Plastic Surgery;2024-03-04
5. Cell therapy for male sexual dysfunctions: systematic review and position statements from the European Society for Sexual Medicine;Sexual Medicine;2024-02-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3